<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101601192</journal-id>
<journal-id journal-id-type="pubmed-jr-id">41009</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Genet Med Rep</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Genet Med Rep</journal-id>
<journal-title-group>
<journal-title>Current genetic medicine reports</journal-title>
</journal-title-group>
<issn pub-type="epub">2167-4876</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27942422</article-id>
<article-id pub-id-type="pmc">5142630</article-id>
<article-id pub-id-type="doi">10.1007/s40142-016-0100-7</article-id>
<article-id pub-id-type="manuscript">NIHMS800237</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Expansion of the RASopathies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tidyman</surname>
<given-names>William E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rauen</surname>
<given-names>Katherine A.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Pediatrics, Division of Behavioral and Developmental Pediatrics, University of California Davis, CA, USA</aff>
<aff id="A2"><label>2</label>UC Davis MIND Institute, Sacramento, CA, USA</aff>
<aff id="A3"><label>3</label>Department of Pediatrics, Division of Genomic Medicine, University of California Davis, CA, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Correspondence to: Katherine A. Rauen, M.D., Ph.D., UC Davis MIND Institute, 2825 50th Street, Room #2284, Sacramento, CA, 95817, Phone: (916) 703-0204, Fax: (916) 703-0243, <email>rauen@ucdavis.edu</email></corresp>
<fn fn-type="COI-statement" id="FN2">
<p><bold>Conflict of Interest</bold>: William E. Tidyman and Katherine A. Rauen declare that they have no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>20</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>1</day>
<month>7</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2017</year>
</pub-date>
<volume>4</volume>
<issue>3</issue>
<fpage>57</fpage>
<lpage>64</lpage>
<!--elocation-id from pubmed: 10.1007/s40142-016-0100-7-->
<self-uri xlink:href="http://link.springer.com/article/10.1007/s40142-016-0100-7"></self-uri>
<abstract>
<p id="P1">The Ras/mitogen activated protein kinase (MAPK) pathway is essential in the regulation of cell cycle, differentiation, growth, cell senescence and apoptosis, all of which are critical to normal development. A class of neurodevelopmental disorders, RASopathies, is caused by germline mutations in genes of the Ras/MAPK pathway. Through the use of whole exome sequencing and targeted sequencing of selected genes in cohorts of panel-negative RASopathy patients, several new genes have been identified. These include: <italic>RIT1, SOS2, RASA2, RRAS</italic> and <italic>SYNGAP1</italic>, that likely represent new, albeit rare, causative RASopathy genes. In addition, <italic>A2ML1, LZTR1</italic>, <italic>MYST4</italic>, <italic>SPRY1</italic> and <italic>MAP3K8</italic> may represent new rare genes for RASopathies, but, additional functional studies regarding the mutations are warranted. In addition, recent reports have demonstrated that chromosomal copy number variation in regions encompassing Ras/MAPK pathway genes may be a novel pathogenetic mechanism expanding the RASopathies.</p>
</abstract>
<kwd-group>
<kwd>Noonan syndrome</kwd>
<kwd>RASopathy</kwd>
<kwd>Ras/MAPK pathway</kwd>
<kwd>RASA2</kwd>
<kwd>RIT1</kwd>
<kwd>RRAS</kwd>
<kwd>signal transduction</kwd>
<kwd>SYNGAP</kwd>
<kwd>SPRY1</kwd>
<kwd>MYST4</kwd>
<kwd>MAP3K8</kwd>
<kwd>A2ML1</kwd>
<kwd>LZTR1</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>